DALLAS, July 11, 2025 /PRNewswire/ -- Braemar Hotels & Resorts Inc. (NYSE: BHR) ("Braemar" or the "Company") announced today that its Board of Directors (the "Board") declared a quarterly cash dividend of $0.05 per diluted share for the Company's common stock for the third quarter ending September 30, 2025. This dividend, which equates to an annual rate of $0.20 per share, is payable on October 15, 2025, to stockholders of record as of September 30, 2025.The Board declared a quarterly cash dividend for the ...

SARASOTA, Fla., July 01, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it has entered into a placement agency agreement for the purchase and sale of up to 800,000 shares of the Company’s Series H Convertible Preferred Stock (“Preferred Stock”), no par value, and Warrants to purchase up to an additional 800,000 shares of Preferred Stock of the Company at an ex ...

NEW YORK, June 27, 2025 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") announced today that, pursuant to a securities purchase agreement (the “Purchase Agreement”) with Blue Harbour Asset Management L.L.C-FZ (“Blue Harbour”), it has completed a private placement of the Company’s newly designated Series C Convertible Preferred Stock (the “Preferred Stock”). Pursuant to the Purchase Agreement, Blue Harbour purchased 60,000 shares of Preferred Stock for an aggregate p ...

Core Insights - Luminar has secured a deal with Yorkville Advisors Global and another unnamed investor to raise up to $200 million through the sale of convertible preferred stock over an 18-month period [1] - The company has undergone significant leadership changes, with founder Austin Russell replaced by Paul Ricci as CEO and board chair, alongside a new round of layoffs [2] Financial Arrangement - Luminar will initially issue $35 million in convertible preferred stock, with the option to issue additional tranches of up to $35 million every 60 days at a purchase price of 96% of the stated value [3] - The proceeds from the initial issuance are intended for general corporate purposes and debt retirement, enhancing the company's financial flexibility [4] Company Background - Luminar was founded in 2012 and gained prominence during the autonomous vehicle technology boom, merging with Gores Metropoulos Inc. in 2021 at a market valuation of $3.4 billion, but currently has a market cap of $179 million [5][7] - The company has faced challenges, including multiple restructurings and a workforce reduction of about 30% in 2024, resulting in the layoff of 212 employees [8]

Core Viewpoint - Beneficient has successfully closed a $233,333 primary capital commitment for Cork & Vines Fund I, LP, marking its second GP Primary transaction of the fiscal year and third since the program's launch in late 2024 [1][2][3] Group 1: Transaction Details - The Fund received approximately $233,333 in shares of Beneficient's Resettable Convertible Preferred Stock, which can be converted into Class A common stock [2] - This transaction is expected to increase the collateral for Beneficient's ExAlt loan portfolio by approximately $233,333 in alternative asset interests [2] - Beneficient has entered into a Preferred Liquidity Provider Program Agreement with the Fund to facilitate ongoing liquidity solutions for the Fund and its limited partners [2] Group 2: Financial Impact - The transaction is anticipated to add approximately $77,777 to the tangible book value attributable to Beneficient's stockholders, contributing to an aggregate of approximately $10.54 million [3] - Beneficient's GP Primary Commitment Program aims to address the potential demand for primary commitments, estimated at up to $330 billion, to support fundraising efforts [4] Group 3: Company Overview - Beneficient is focused on democratizing the global alternative asset investment market by providing solutions for mid-to-high net worth individuals and small-to-midsized institutions [12] - The company's AltAccess platform offers a secure online environment for customers to explore investment opportunities and receive proposals [12]

NEW YORK, April 11, 2025 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") announced today that, pursuant to a securities purchase agreement (the “Purchase Agreement”) with Blue Harbour Asset Management L.L.C-FZ (“Blue Harbour”), it has completed a private placement of the Company’s newly designated Series B Convertible Preferred Stock (the “Preferred Stock”). Pursuant to the Purchase Agreement, Blue Harbour purchased 100,000 shares of Preferred Stock for an aggregate ...

Core Insights - Beneficient has successfully closed a $9.6 million primary capital commitment for Pulse Pioneer Fund, marking its first GP Primary transaction of the fiscal year [1][2] - The financing is expected to enhance the collateral for the Company's ExAlt loan portfolio by approximately $9.6 million in alternative assets [1] - The transaction is anticipated to add around $1.28 million to the tangible book value for the Company's stockholders, totaling approximately $10.46 million post-transaction [2] Company Strategy - Beneficient's GP Primary Commitment Program aims to provide primary capital solutions and anchor commitments to general partners, addressing a potential demand of up to $330 billion for primary commitments [3] - The management emphasizes the importance of innovative financing solutions to enhance shareholder value and support impactful investment strategies [2] Financial Metrics - As of December 31, 2024, the tangible book value attributable to the Company's stockholders is projected to increase from $9,177 thousand to $10,457 thousand post-transaction [5][6] - The total equity (deficit) stands at $14,260 thousand, with a tangible book value of $91,772 thousand before the transaction [5] Company Overview - Beneficient operates a technology-enabled platform that provides exit opportunities and primary capital solutions for holders of alternative assets through its online platform, AltAccess [1][7] - The Company aims to democratize the alternative asset investment market for mid-to-high net worth individuals and small to midsized institutions [7]